First human trial launches for brain cancer vaccine
Disease control
Not yet recruiting
This early-phase trial tests a new personalized vaccine called Bvax, made from each patient's own cells, combined with standard chemoradiation for newly diagnosed glioblastoma. The study will enroll 25 people to check safety and see if the vaccine helps control the cancer. It is …
Phase: PHASE1 • Sponsor: Catalina Lee Chang • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC